期刊文献+

白细胞介素-23通过无翅基因相关整合位点/β-连环蛋白通路增强舌鳞状细胞癌抗凋亡及耐药能力 被引量:3

Interleukin-23 strengthens the anti-apoptotic and drug resistance of human tongue squamous cell carcinoma through the Wingless-related integration site/β-catenin pathway
下载PDF
导出
摘要 目的检测白细胞介素-23(IL-23)在舌鳞状细胞癌组织中表达水平与临床预后的关系,研究舌鳞状细胞癌细胞系SCC9经IL-23处理后抗凋亡及耐药能力的变化。方法免疫组织化学法检测28例舌鳞状细胞癌患者组织中IL-23的表达情况;实时定量聚合酶链反应(q RT-PCR)检测不同浓度的IL-23处理后,SCC9中无翅基因相关整合位点(Wnt)1及c-myc的m RNA表达水平;结合小分子干扰RNA(si RNA),Western blot法检测IL-23对SCC9细胞的β-连环蛋白(β-catenin)和B淋巴细胞瘤-2(Bcl-2)、三磷酸腺苷结合转运蛋白G超家族成员2(ABCG2)、P-糖蛋白(P-gp)表达影响及潜在机制;甲基噻唑基四唑法检测SCC9细胞在IL-23作用下对顺铂的抗凋亡能力改变。结果舌鳞状细胞癌组织中IL-23表达强度与淋巴结转移、神经侵犯及治疗复发有相关性(P<0.05);IL-23可增强癌细胞抗凋亡蛋白Bcl-2和耐药相关蛋白ABCG2、P-gp的表达,并且与Wnt通路活化程度密切相关;IL-23能够显著加强SCC9细胞对顺铂的抵抗性(P<0.01)。结论 IL-23通过上调舌鳞状细胞癌细胞的Wnt通路增强其抗凋亡及耐药能力。 ObjectiveThis study aims to detect the expression level of interleukin-23 (IL-23) in tongue squamous cell carcinoma tissues and its relationship with clinical prognosis, as well as explore the anti-apoptotic and drug resistance of the tongue squamous cell line-SCC9 before and after treatment with IL-23. Methods The expression of IL-23 in tumor tissues from 28 tongue cancer patients was analyzed by immunohistochemistry assay. Quantitative real-time polymerase chain reac-tion (qRT-PCR) was used to detect the mRNA expression of Wingless-related integration site (Wnt)1 and c-myc in SCC9 cells treated with different IL-23 concentrations. After interferencing the β-catenin with small interfering RNA (siRNA), the expres-sion of β-catenin, B-cell lymphoma-2 (Bcl-2), ATP-binding cassette sub-family G member 2 (ABCG2), and permeability-glycoprotein (P-gp) in SCC9 was measured by Western blot analysis. The effect of IL-23 on the apoptotic resistance of SCC9 to cisplatin was examined by methyl thiazolyl tetrazolium test. Results The expression of IL-23 in tongue cancer tissues was correlated with lymphatic metastasis, nerve invasion, and the recurrence after therapy (P〈0.05). After dealing with IL-23, SCC9 showed the upregulation effect of Bcl-2, ABCG2 and P-gp expressions. IL-23 was closely related to the activation level of the Wnt pathway and significantly strengthened the resistance to cisplatin (P〈0.01). Conclusion IL-23 activates the Wnt pathway in tongue squamous cell carcinoma, thereby enhancing its resistance to apoptosis and drug.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2015年第3期249-254,共6页 West China Journal of Stomatology
关键词 白细胞介素-23 舌鳞状细胞癌 耐药 抗凋亡 无翅基因相关整合位点 interleukin-23 tongue squamous cell carcinoma drug resistance anti-apoptosis Wingless-related integration site
  • 相关文献

参考文献19

  • 1de Camargo Cancela M, Voti L, Guerra-Yi M, et al. Oral cavity cancer in developed and in developing countries: population-based incidence[J]. Head Neck, 2010, 32(3): 357-367.
  • 2Cooper JS, Porter K, Mallin K, et al. National Cancer Data- base report on cancer of the head and neck: 10-year update [J]. Head Neck, 2009, 31 (6):748-758.
  • 3郑家伟,李金忠,钟来平,张志愿.口腔鳞状细胞癌临床流行病学研究现状[J].中国口腔颌面外科杂志,2007,5(2):83-90. 被引量:87
  • 4Rumjanek VM, Vidal RS, Maia RC. Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines[J]. Biosci Rep, 2013, 33(6):e00081.
  • 5van Oosterwijk JG, Herpers B, Meijer D, et al. Restoration of chemosensitivity for doxorubicin and cisplatin in chondro- sarcoma in vitro: BCL-2 family members cause chemoresis- tance[J]. Ann Oncol, 2012, 23(6):1617-1626.
  • 6Shen B, Li D, Dong P, et al. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma[J]. Ann Otol Rhinol Laryngol, 2011, 120(12): 820-827.
  • 7Haufroid V. Genetic polymorphisms of ATP-binding cas- sette transporters ABCBI and ABCC2 and their impact on drug disposition[J]. Curr Drug Targets, 2011, 12(5):631-646.
  • 8Ishikawa T, Onishi Y, Hirano H, et al. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB 1 (P-glycoprotein/ MDR1)[J]. Biol Pharm Bull, 2004, 27(7):939-948.
  • 9Bruhn O, Cascorbi I. Polymorphisms of the drug transpor- ters ABCB 1, ABCG2, ABCC2 and ABCC3 and their im- pact on drug bioavailability and clinical relevance[J]. Expert Opin Drug Metab Toxicol, 2014, 10(10):1337-1354.
  • 10Bjorklund CC, Ma W, Wang ZQ, et al. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide[J]. J Biol Chem, 2011,286 (13)'1 t009-11020.

二级参考文献62

  • 1[1]Kufe DW,Holland JF,Frei E,American Cancer Society.Cancer medicine[M].6th Edition.Lewiston:BC Decker,2003:2.
  • 2[2]Mignogna MD,Felele S,Russo LL.The World Cancer Report and the burden of oral cancer[J].Eur J Cancer Prev,2004,13(2):139-142.
  • 3[3]Howell RE,Wright BA,Dewar R.Trends in the incidence of oral cancer in Nova Scotia from 1983 to 1997[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2003,95(2):205-212.
  • 4[4]Wunsch-Filho V.The epidemiology of oral and pharynx cancer in Brazil[J].Oral Oncol,2002,38(8):737-746.
  • 5[5]Bosetti C,Franceschi S,Negri E,et al.Changing socioeconomic correlates for cancers of the upper digestive tract[J].Ann Oncol,2001,12(3):327-330.
  • 6[6]Mignogna MD,Fedele S,Russo LL.The World Cancer Report and the burden of oral cancer[J].Eur J Cancer Prev,2004,13(2):139-142
  • 7[7]Zavras AI,Laskaris C,Kitta C,et al.Leukoplakia and intraoral malignancies.Female cases increase in Greece[J].J Eur Acad Dermatol Venereol,2003,17(1):25-27.
  • 8[8]O'Sullivan EM.Oral and pharyngeal cancer in Ireland[J].Ir Med J,2005,98(4):102-105.
  • 9[9]Llewellyn CD,Johnson NW,Warnakulasuriya KA.Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger:a case-control study in Southern England[J].J Oral Pathol Med,2004,33(9):525-532.
  • 10[10]Tarvainen L,Suuronen R,Linqvist C,et al.Is the incidence oforal and pharyngeal cancer increasing in Finland? An epidemiological study of 17,383 cases in 1953-1999[J].Oral Dis,2004,10(3):167-172.

共引文献86

同被引文献28

  • 1姚金光,邝晓聪,温冠媚,李祖云,李俊.舌鳞状细胞癌淋巴道转移裸鼠模型建立的实验研究[J].右江医学,2006,34(6):581-583. 被引量:8
  • 2Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015 [ J ]. CA Cancer J Clin, 2016,66 (2) : 115- 132.
  • 3Wang R, Sun Q,Wang P, et al.Notch and Wnt/13-catenin signaling pathway play important roles in activating liver cancer stem cells [ J ]. Oncotarget, 2016,7 ( 5 ) : 5754-5768.
  • 4Testa U. Leukemia stem cells [ J ]. Ann Hematol, 2011,90 (3) :245-271.
  • 5Reya T, Morrison S J, Clarke MF, et al.Stem cells, cancer, and cancer stem cells[J] .Nature,2001,414(6859) :105- 111.
  • 6Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis [ J ].Science, 2011,331 (6024) : 1559-1564.
  • 7Zhu L, Zhang W, Wang J, et al.Evidence of CD90+CXCR4 +cells as circulating tumor stem cells in hepatocellular carcinoma [ J ].Tumour Biol, 2015,36 ( 7 ) : 5353-5360.
  • 8Yao J, Cai HH, Wei JS, et al.Side population in the pan- creatic cancer cell lines SW1990 and CFPAC-1 is en- riched with cancer stem-like cells [ J ]. Oncol Rep, 2010, 23(5) : 1375-1382.
  • 9AI-Hajj M, Wicha MS, Benito-Hernandez A, et al.Prospec- tire identification of tumorigenic breast cancer cells [ J ]. Proc Natl Aead Sci USA,2003,100(7) :3983-3988.
  • 10Gu G, Yuan J, Wills M, et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo[ J] .Cancer Res,2007,67(10) :4807-4815.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部